Low PAPP‐A: what are the clinical implications?

Ultrasound and pulsed Doppler can assist in confirming impaired placentation looking at fetal biometry and umbilical artery Dopplers. The authors recommend confirmation of fetal wellbeing at 28–30 weeks with a PAPP‐A level below the first centile.

Saved in:
Bibliographic Details
Published in:Australasian journal of ultrasound in medicine 2012-02, Vol.15 (1), p.26-28
Main Authors: Lau, Harmonie, Amarasekara, Chaminda, Uppal, Talat
Format: Article
Language:English
Subjects:
Case Study
maternal serum
PAPP‐A
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83
cites cdi_FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83
container_end_page 28
container_issue 1
container_start_page 26
container_title Australasian journal of ultrasound in medicine
container_volume 15
creator Lau, Harmonie
Amarasekara, Chaminda
Uppal, Talat
description Ultrasound and pulsed Doppler can assist in confirming impaired placentation looking at fetal biometry and umbilical artery Dopplers. The authors recommend confirmation of fetal wellbeing at 28–30 weeks with a PAPP‐A level below the first centile.
doi_str_mv 10.1002/j.2205-0140.2012.tb00139.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5025130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3078668479</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83</originalsourceid><addsrcrecordid>eNqVkE1OwzAQRi0EolXpFVAE64SxnThOF6Co4ldFdEHXluM4NFWaFCel7Y4jcEZOgkNLBUtWHul783n0EDrD4GEAcjHzCIHABeyDRwATr0kAMI289QHq7qND1MWcMpdx5ndQv65nYCkGQMPwGHUIxxHGlHURHlUrZxyPx5_vH_HAWU1l40ijnWaqHVXkZa5k4eTzRWGHJq_K-uoEHWWyqHV_9_bQ5Ob6eXjnjp5u74fxyFU08iOXJNwHSbBSYRokWmEmSagDnklOFQ8UpX6qwGaMKMJ9kqqQBzKBLMl0RDWnPXS57V0sk7lOlS4bIwuxMPlcmo2oZC7-JmU-FS_VmwiABJiCLTjfFZjqdanrRsyqpSntzYJCyBnjfhhZarCllKnq2uhs_wMG0RoXM9FqFa1W0RoXO-NibZdPf9-4X_3xa4F4C6zyQm_-US3ih8nj90y_AHiPkO0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3078668479</pqid></control><display><type>article</type><title>Low PAPP‐A: what are the clinical implications?</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><source>PubMed Central(OpenAccess)</source><creator>Lau, Harmonie ; Amarasekara, Chaminda ; Uppal, Talat</creator><creatorcontrib>Lau, Harmonie ; Amarasekara, Chaminda ; Uppal, Talat</creatorcontrib><description>Ultrasound and pulsed Doppler can assist in confirming impaired placentation looking at fetal biometry and umbilical artery Dopplers. The authors recommend confirmation of fetal wellbeing at 28–30 weeks with a PAPP‐A level below the first centile.</description><identifier>ISSN: 1836-6864</identifier><identifier>EISSN: 2205-0140</identifier><identifier>EISSN: 1836-6864</identifier><identifier>DOI: 10.1002/j.2205-0140.2012.tb00139.x</identifier><identifier>PMID: 28191136</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Case Study ; maternal serum ; PAPP‐A</subject><ispartof>Australasian journal of ultrasound in medicine, 2012-02, Vol.15 (1), p.26-28</ispartof><rights>2012 Australasian Society for Ultrasound in Medicine</rights><rights>Australasian Society for Ultrasound in Medicine</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83</citedby><cites>FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025130/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025130/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28191136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lau, Harmonie</creatorcontrib><creatorcontrib>Amarasekara, Chaminda</creatorcontrib><creatorcontrib>Uppal, Talat</creatorcontrib><title>Low PAPP‐A: what are the clinical implications?</title><title>Australasian journal of ultrasound in medicine</title><addtitle>Australas J Ultrasound Med</addtitle><description>Ultrasound and pulsed Doppler can assist in confirming impaired placentation looking at fetal biometry and umbilical artery Dopplers. The authors recommend confirmation of fetal wellbeing at 28–30 weeks with a PAPP‐A level below the first centile.</description><subject>Case Study</subject><subject>maternal serum</subject><subject>PAPP‐A</subject><issn>1836-6864</issn><issn>2205-0140</issn><issn>1836-6864</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqVkE1OwzAQRi0EolXpFVAE64SxnThOF6Co4ldFdEHXluM4NFWaFCel7Y4jcEZOgkNLBUtWHul783n0EDrD4GEAcjHzCIHABeyDRwATr0kAMI289QHq7qND1MWcMpdx5ndQv65nYCkGQMPwGHUIxxHGlHURHlUrZxyPx5_vH_HAWU1l40ijnWaqHVXkZa5k4eTzRWGHJq_K-uoEHWWyqHV_9_bQ5Ob6eXjnjp5u74fxyFU08iOXJNwHSbBSYRokWmEmSagDnklOFQ8UpX6qwGaMKMJ9kqqQBzKBLMl0RDWnPXS57V0sk7lOlS4bIwuxMPlcmo2oZC7-JmU-FS_VmwiABJiCLTjfFZjqdanrRsyqpSntzYJCyBnjfhhZarCllKnq2uhs_wMG0RoXM9FqFa1W0RoXO-NibZdPf9-4X_3xa4F4C6zyQm_-US3ih8nj90y_AHiPkO0</recordid><startdate>201202</startdate><enddate>201202</enddate><creator>Lau, Harmonie</creator><creator>Amarasekara, Chaminda</creator><creator>Uppal, Talat</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>201202</creationdate><title>Low PAPP‐A: what are the clinical implications?</title><author>Lau, Harmonie ; Amarasekara, Chaminda ; Uppal, Talat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Case Study</topic><topic>maternal serum</topic><topic>PAPP‐A</topic><toplevel>online_resources</toplevel><creatorcontrib>Lau, Harmonie</creatorcontrib><creatorcontrib>Amarasekara, Chaminda</creatorcontrib><creatorcontrib>Uppal, Talat</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Australasian journal of ultrasound in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lau, Harmonie</au><au>Amarasekara, Chaminda</au><au>Uppal, Talat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low PAPP‐A: what are the clinical implications?</atitle><jtitle>Australasian journal of ultrasound in medicine</jtitle><addtitle>Australas J Ultrasound Med</addtitle><date>2012-02</date><risdate>2012</risdate><volume>15</volume><issue>1</issue><spage>26</spage><epage>28</epage><pages>26-28</pages><issn>1836-6864</issn><eissn>2205-0140</eissn><eissn>1836-6864</eissn><abstract>Ultrasound and pulsed Doppler can assist in confirming impaired placentation looking at fetal biometry and umbilical artery Dopplers. The authors recommend confirmation of fetal wellbeing at 28–30 weeks with a PAPP‐A level below the first centile.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28191136</pmid><doi>10.1002/j.2205-0140.2012.tb00139.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1836-6864
ispartof Australasian journal of ultrasound in medicine, 2012-02, Vol.15 (1), p.26-28
issn 1836-6864
2205-0140
1836-6864
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5025130
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list); PubMed Central(OpenAccess)
subjects Case Study
maternal serum
PAPP‐A
title Low PAPP‐A: what are the clinical implications?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A38%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20PAPP%E2%80%90A:%20what%20are%20the%20clinical%20implications?&rft.jtitle=Australasian%20journal%20of%20ultrasound%20in%20medicine&rft.au=Lau,%20Harmonie&rft.date=2012-02&rft.volume=15&rft.issue=1&rft.spage=26&rft.epage=28&rft.pages=26-28&rft.issn=1836-6864&rft.eissn=2205-0140&rft_id=info:doi/10.1002/j.2205-0140.2012.tb00139.x&rft_dat=%3Cproquest_pubme%3E3078668479%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3949-2b840a21cc7d5bec16a27e58fa83c85c334dc07d562c2842dc785ab0fbfe93e83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3078668479&rft_id=info:pmid/28191136&rfr_iscdi=true